Digital Pathology Market: Growth, Size, Share, and Trends

Report Code HIT 2608
Published in Jul, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2029

Overview

The global digital pathology market, valued at US$0.9 billion in 2023, is forecasted to grow at a robust CAGR of 13.1%, reaching US$1.1 billion in 2024 and an impressive US$2.0 billion by 2029. The growth of the market is primarily driven by the rising demand for telepathology solutions, which allow pathologists to review cases remotely and consult globally in real-time, as well as government funding, growing applications in drug development, and companion diagnostics. Moreover, the integration of AI algorithms with digital scanners has opened new opportunities for predictive analytics, further contributing to market growth. For instance, Roche (Switzerland) collaborated with PathAI (US) to develop an AI-enabled digital pathology algorithm for companion diagnostics. However, the shortage of skilled pathologists, high implementation costs, and concerns about reimbursement pose challenges to market growth.

Attractive Opportunities in the Digital Pathology Market

Asia Pacific

The Asia Pacific market is expected to grow at the second-highest rate during the forecast period owing to the rising geriatric population and increasing incidence of chronic conditions.

The demand for digital pathology solutions is majorly driven by the rising prevalence of cancer and growing applications of digital pathology in drug development and companion diagnostics.

Product launches, upgrades, & approvals and partnerships would offer lucrative opportunities for market players in the next 5 years.

Market growth in North America can be attributed to the well-developed research infrastructure, availability of key players

The growth opportunities in emerging markets, and growing applications of imaging technology offer several opportunities for market growth.

Global Digital Pathology Market Dynamics

Driver: Advancements in Technology

Technological advancements like whole-slide imaging (WSI), image analysis software, and artificial intelligence (AI) have revolutionized digital pathology. These innovations have significantly enhanced diagnostic precision, operational efficiency, and automated workflow processes, thereby increasing the appeal of digital pathology among healthcare providers.Digital pathology enables telepathology, where pathologists can review slides remotely. This capability is crucial for areas with limited access to pathology expertise, leading to improved patient care outcomes through faster diagnosis and treatment.

Restraint: Workflow Integration

Integrating digital pathology systems into existing laboratory workflows can be complex. It may require changes in processes and training for pathologists and laboratory technicians. Ensuring seamless integration with existing laboratory information systems (LIS) and electronic health records (EHR) is crucial but challenging.

 

Opportunity: AI and Machine learning applications

Artificial intelligence (AI) and machine learning (ML) are becoming integral to digital pathology, aiding pathologists in identifying abnormalities, measuring biomarkers, and forecasting outcomes through image analysis. These AI tools hold promise in boosting diagnostic precision, minimizing mistakes, and refining treatment strategies, ultimately leading to better patient results. Over the past two decades, global scientific publications on AI have surged more than sixfold, exceeding 60,000 annually. Reflecting this interest, at least 26 governments have developed national AI strategies in recent years. These technologies have the potential to enhance diagnostic accuracy, streamline workflow efficiency, and improve patient outcomes.

Challenge: Cost of Implementation

Moving from traditional microscopy to digital pathology requires substantial initial investments. These encompass acquiring digital slide scanners, setting up storage systems for vast image files, and establishing IT infrastructure capable of managing and processing digital pathology data. These expenses may pose challenges, particularly for smaller laboratories or healthcare facilities with limited financial resources.

Global Digital Pathology Market Ecosystem Analysis

Digital Pathology Market Map & Ecosystem Overview The digital pathology market’s ecosystem comprises entities responsible for delivering digital pathology solutions to end users via various deployment models. The demand continues to grow and expand as enterprises implement digital pathology software to reduce costs and optimize the workload performance of their health systems. Solution and service providers continue to enhance and mature their offerings to increase the value addition. Solution providers in the digital pathology market develop high-end digital pathology solutions based on the customer’s requirements.

 

By product, software segment is the fastest growing in the digital pathology industry in 2023.

By product, the digital pathology market is segmented into scanners, software, and systems segments. The software segment registers the highest CAGR during the forecast period. The software segment in the digital pathology market is growing rapidly due to several factors. Advancements in AI and machine learning are enhancing the analysis of pathology data, improving diagnostic accuracy and efficiency. AI-powered software helps pathologists detect patterns and anomalies in digital images that may be overlooked otherwise. Additionally, software solutions are crucial for integrating digital pathology systems with existing healthcare IT infrastructure, such as EHR and LIS, streamlining workflows and improving data accessibility.

By type, the human pathology segment of the digital pathology industry registers the highest growth rate during the forecast period.

Based on type, the digital pathology market is segmented into human pathology and veterinary pathology. Human pathology registers a high growth rate during forecast period due to the rising prevalence of chronic diseases such as cancer. Digital pathology has significant potential in human specimen slide analysis. It also improves productivity and efficiency for healthcare providers and reduces manual errors. Owing to this, companies are adopting organic strategies. For instance, In March 2024, Koninklijke Philips N.V (Netherlands) and Amazon Web Services (AWS) announced an expanded collaboration with AWS to address the growing need for secure, scalable digital pathology solutions in the cloud. This collaboration will help to accelerate workflow efficacy and will help in enabling seamless integration with existing healthcare system to deliver holistic patient care.

North America Region Holds the Largest Share of the Digital Pathology Market.

The digital pathology market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2023, North America accounted for the largest share of the Digital Pathology market. This is due to its advanced healthcare infrastructure and significant investment in healthcare technologies, Additionally, North America, particularly US, has a high prevalence of cancer, driving the demand for efficient and accurate diagnostic tools.

 
 

Recent Developments of Digital Pathology Market industry

  • In March 2024, Koninklijke Philips N.V. (Netherlands) announced an expanded collaboration with AWS to address the growing need for secure, scalable digital pathology solutions in the cloud. This collaboration will help to accelerate workflow efficacy and will help in enabling seamless integration with existing healthcare systems to deliver holistic patient care.
  • In February 2024, Roche announced its collaboration with Path AI to develop AI-enabled digital pathology algorithms in the companion diagnostics space. This collaboration will allow Roche to accelerate its ability to meet the demand from biopharma companies looking to develop AI-enabled companion diagnostics and provide end-to-end solutions.

Key Market Players

KEY PLAYERS IN THE Digital Pathology Market INCLUDE

  • Fujifilm Holdings Corporation (Japan)
  •  Danaher Corporation
  • Koninklijke Philips N.V.
  • Mikroscan Technologies, Inc. 
  • PathAI
  • Hamamatsu Photonics K.K.
  • F. Hoffmann-La Roche Ltd
  •  3DHISTECH 
  • Apollo Enterprise Imaging
  • XIFIN, Inc. 
  • Proscia Inc
  • KONFOONG BIOTECH INTERNATIONAL
  • Sectra AB

Want to explore hidden markets that can drive new revenue in Digital Pathology Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2024 USD 1.1 billion
Projected Revenue by 2029 USD 2.0 billion
Revenue Rate Poised to Grow at a CAGR of 13.1%
Market Driver Advancements in Technology
Market Opportunity AI and Machine learning applications

 

Key Questions Addressed by the Report

What is the projected growth rate and market value of the global digital pathology market?
The global digital pathology market is projected to grow from USD 1.1 billion in 2024 to USD 2.0 billion by 2029, demonstrating a robust CAGR of 13.1%.
What are the key factors driving the digital pathology market?
The key drivers of the digital pathology market include advancements in AI and machine learning, the rising demand for telepathology solutions, and increasing government funding for healthcare technologies and drug development.
What are the challenges facing the digital pathology market?
The digital pathology market faces challenges such as high implementation costs, the complexity of integrating systems into existing laboratory workflows, and the shortage of skilled pathologists to manage advanced technologies.
Which regions are expected to show growth in the digital pathology market?
North America is expected to dominate the digital pathology market, driven by advanced healthcare infrastructure, high prevalence of diseases like cancer, and significant investments in healthcare technologies. Other regions with growth potential include Europe and Asia Pacific.
What advancements in technology are influencing the digital pathology market?
Advancements such as whole-slide imaging (WSI), AI-powered image analysis software, and integration with digital scanners are significantly improving the diagnostic precision and operational efficiency in digital pathology, further driving market growth.
How does the integration of AI impact the digital pathology market?
AI and machine learning applications are revolutionizing digital pathology by enhancing diagnostic accuracy, identifying abnormalities, and streamlining workflows. These technologies help pathologists detect patterns that may have been overlooked, improving overall patient outcomes.
What are the key products in the digital pathology market?
Key products in digital pathology include digital slide scanners, AI-powered software for image analysis, and integrated pathology systems that combine software and hardware for enhanced workflow efficiency and diagnostic capabilities.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Digital Pathology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
29
RESEARCH METHODOLOGY
34
EXECUTIVE SUMMARY
49
PREMIUM INSIGHTS
53
MARKET OVERVIEW
57
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rising incidence of cancer and chronic diseases
    - Increasing adoption of digital pathology solutions to enhance lab efficiency
    - Growing applications in drug development and companion diagnostics
    - Rising awareness of early cancer diagnosis in emerging markets
    RESTRAINTS
    - High cost of digital pathology systems
    OPPORTUNITIES
    - Introduction of affordable scanners for private pathology practices
    - Growing preference for personalized medicine
    - High growth potential of emerging economies
    CHALLENGES
    - Shortage of skilled pathologists
  • 5.3 INDUSTRY TRENDS
    TELEPATHOLOGY
    MULTIPLEXING
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - AI in digital pathology
    - Label-free imaging in digital pathology
    - Computational image analysis in digital pathology
    ADJACENT TECHNOLOGIES
    - Genomic sequencing
    COMPLEMENTARY TECHNOLOGIES
    - Molecular imaging
  • 5.5 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND, BY REGION
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.9 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY ANALYSIS
    - North America
    - Europe
    - Asia Pacific
  • 5.10 HS CODES FOR DIGITAL PATHOLOGY SCANNERS
  • 5.11 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS
    JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIGITAL PATHOLOGY PATENTS
    MAJOR PATENTS
  • 5.12 CASE STUDY ANALYSIS
  • 5.13 KEY CONFERENCES & EVENTS, 2024–2025
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.15 END-USER ANALYSIS
    UNMET NEEDS
    END-USER EXPECTATIONS
  • 5.16 BUSINESS MODEL ANALYSIS
  • 5.17 INVESTMENT & FUNDING SCENARIO
  • 5.18 IMPACT OF GENERATIVE AI ON DIGITAL PATHOLOGY MARKET
    TOP USE CASES & MARKET POTENTIAL
    - Key Use Cases
    CASE STUDIES OF GENERATIVE AI IMPLEMENTATION
    - Case Study 1: Healthcare - Enhancing Medical Imaging
    - Case study 2: Combining generative AI with biosensors and lab-on-a-chip technology
    - Case study 3: Impact of Gen AI-based Digital pathology: the Korean experience
    - AI in pathology market
    - Tissue diagnostics market
    - Anatomic pathology market
    USER READINESS AND IMPACT ASSESSMENT
    - User readiness
    - Impact assessment
DIGITAL PATHOLOGY MARKET, BY PRODUCT
95
  • 6.1 INTRODUCTION
  • 6.2 SCANNERS
    BRIGHTFIELD SCANNERS
    - Cost-efficient features to boost demand
    FLUORESCENCE SCANNERS
    - Ability to detect cellular structures and biomarkers to fuel uptake
    OTHER SCANNERS
  • 6.3 SOFTWARE, BY TYPE
    INTEGRATED SOFTWARE
    - Single & effective suite for multiple applications to propel market
    STANDALONE SOFTWARE
    - Information management software
    - Image analysis software
  • 6.4 SOFTWARE, BY DEPLOYMENT MODEL
    CLOUD-BASED MODEL
    - Benefits of cloud-based models and ease of access to drive market
    ON-PREMISE MODEL
    - High data security and integration with HCIT solutions to fuel uptake
    HYBRID MODEL
    - Combined flexibility to support market growth
  • 6.5 STORAGE SYSTEMS
    GROWING FOCUS ON STORAGE OF HIGH-RESOLUTION IMAGES TO DRIVE MARKET
DIGITAL PATHOLOGY MARKET, BY TYPE
121
  • 7.1 INTRODUCTION
  • 7.2 HUMAN PATHOLOGY
    INCREASING CANCER RESEARCH ACTIVITIES TO PROPEL MARKET
  • 7.3 VETERINARY PATHOLOGY
    IMPROVEMENTS IN ANIMAL DISEASE DIAGNOSTICS TO SUPPORT MARKET GROWTH
DIGITAL PATHOLOGY MARKET, BY APPLICATION
125
  • 8.1 INTRODUCTION
  • 8.2 DRUG DISCOVERY
    INCREASING FOCUS ON LIFE SCIENCES R&D TO DRIVE MARKET
  • 8.3 DISEASE DIAGNOSIS
    INTEGRATION OF AI & ML IN COMPLEX DIAGNOSTICS TO BOOST DEMAND
  • 8.4 TRAINING & EDUCATION
    ABILITY TO PROVIDE REAL-TIME LEARNING EXPERIENCES TO SUPPORT MARKET GROWTH
DIGITAL PATHOLOGY MARKET, BY END USER
131
  • 9.1 INTRODUCTION
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    INCREASING FOCUS ON DRUG TOXICOLOGY TESTING AND RISING NUMBER OF PRECLINICAL TRIALS TO PROPEL MARKET
  • 9.3 HOSPITALS AND REFERENCE LABORATORIES
    HIGH INCIDENCE OF INFECTIOUS DISEASES TO BOOST DEMAND
  • 9.4 ACADEMIC & RESEARCH INSTITUTES
    INCREASING PUBLIC & PRIVATE FUNDING INVESTMENTS TO SUPPORT MARKET GROWTH
DIGITAL PATHOLOGY MARKET, BY REGION
138
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    US
    - Favorable reimbursements for diagnostics to drive market
    CANADA
    - Growing awareness of early cancer detection & diagnosis to drive market
  • 10.3 EUROPE
    GERMANY
    - High healthcare expenditure and supportive research initiatives to drive market
    UK
    - Government funding investments for pathology services to fuel market
    SWEDEN
    - Increasing prevalence of chronic diseases to support market growth
    DENMARK
    - Increasing deployment of digital pathology solutions to support market growth
    FRANCE
    - Increasing government funding and favorable insurance system to drive adoption
    SPAIN
    - Supportive collaborations among leading companies and hospitals to boost demand
    ITALY
    - Integration of AI & ML to support market growth
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    CHINA
    - Increasing establishment of hospitals and reference laboratories to drive market
    JAPAN
    - Advanced healthcare infrastructure to support market growth
    INDIA
    - Growth in pharmaceutical industry to propel market
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    BRAZIL
    - High adoption of POC testing to drive market
    MEXICO
    - Growth in companion diagnostics to fuel uptake
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
    GCC COUNTRIES
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
227
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DIGITAL PATHOLOGY MARKET
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Product footprint
    - Application footprint
    - End-user footprint
    - Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 VALUATION & FINANCIAL METRICS
  • 11.8 BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
248
  • 12.1 KEY COMPANIES
    DANAHER CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    KONINKLIJKE PHILIPS N.V.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    HAMAMATSU PHOTONICS K.K.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    F. HOFFMANN-LA ROCHE LTD.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SECTRA AB
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    AKOYA BIOSCIENCES, INC.
    - Business overview
    - Products offered
    - Recent developments
    FUJIFILM HOLDINGS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    HOLOGIC, INC.
    - Business overview
    - Products offered
    - Recent developments
    3DHISTECH LTD.
    - Business overview
    - Products offered
    - Recent developments
    APOLLO ENTERPRISE IMAGING CORP.
    - Business overview
    - Products offered
    - Recent developments
    XIFIN, INC.
    - Business overview
    - Products offered
    - Recent developments
    HURON DIGITAL PATHOLOGY
    - Business overview
    - Products offered
    - Recent developments
    CORISTA
    - Business overview
    - Products offered
    - Recent developments
    INDICA LABS
    - Business overview
    - Products offered
    - Recent developments
    OBJECTIVE PATHOLOGY SERVICES
    - Business overview
    - Products offered
    OPTRASCAN, INC.
    - Business overview
    - Products offered
    - Recent developments
    GLENCOE SOFTWARE, INC.
    - Business overview
    - Products offered
    - Recent developments
    AIFORIA TECHNOLOGIES OY
    - Business overview
    - Products offered
    - Recent developments
    PAIGE AI, INC.
    - Business overview
    - Products offered
    - Recent developments
    PROSCIA, INC.
    - Business overview
    - Products offered
    - Recent developments
  • 12.2 OTHER PLAYERS
    PATHAI
    KONFOONG BIOTECH INTERNATIONAL CO., LTD.
    MIKROSCAN TECHNOLOGIES, INC.
    MOTIC DIGITAL PATHOLOGY
    KANTERON SYSTEMS
    MORPHLE LABS INC.
APPENDIX
308
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 FACTOR ANALYSIS
  • TABLE 2 RISK ASSESSMENT
  • TABLE 3 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
  • TABLE 4 US: GROWTH IN NUMBER OF PERSONALIZED MEDICINES (2008−2020)
  • TABLE 5 NUMBER OF INHABITANTS PER PATHOLOGIST, BY COUNTRY, 2020
  • TABLE 6 AVERAGE SELLING PRICE TREND OF DIGITAL PATHOLOGY PRODUCTS, BY REGION
  • TABLE 7 AVERAGE SELLING PRICE OF DIGITAL PATHOLOGY PRODUCTS
  • TABLE 8 DIGITAL PATHOLOGY MARKET: PORTER’S FIVE FORCES
  • TABLE 9 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 13 EUROPE: CLASSIFICATION OF IVD DEVICES
  • TABLE 14 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 16 HS CODE: DIGITAL PATHOLOGY SCANNER
  • TABLE 17 CASE STUDY 1: ASSESSING IMAGE QUALITY FOR COMPARATIVE MULTI-ASSESSMENT EVALUATION OF APERIO GT 450 DX
  • TABLE 18 CASE STUDY 2: PROMOTION OF PATHOLOGY WORKFLOW EFFICIENCY
  • TABLE 19 CASE STUDY 3: INTEGRATION OF ARTIFICIAL INTELLIGENCE IN DIGITAL PATHOLOGY
  • TABLE 20 DIGITAL PATHOLOGY MARKET: KEY CONFERENCES & EVENTS, 2024−2025
  • TABLE 21 STAKEHOLDERS IN BUYING PROCESS: DEFINITIONS
  • TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DIGITAL PATHOLOGY, BY PRODUCT
  • TABLE 23 KEY BUYING CRITERIA FOR DIGITAL PATHOLOGY PRODUCTS
  • TABLE 24 UNMET NEEDS IN DIGITAL PATHOLOGY MARKET
  • TABLE 25 END-USER EXPECTATIONS IN DIGITAL PATHOLOGY MARKET
  • TABLE 26 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 27 SCANNING MAGNIFICATION AND APPLICATIONS
  • TABLE 28 DIGITAL PATHOLOGY SCANNERS OFFERED BY KEY MARKET PLAYERS
  • TABLE 29 DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 30 DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 BRIGHTFIELD SCANNERS OFFERED BY KEY MARKET PLAYERS
  • TABLE 32 BRIGHTFIELD SCANNERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 FLUORESCENCE SCANNERS OFFERED BY KEY MARKET PLAYERS
  • TABLE 34 FLUORESCENCE SCANNERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 OTHER SCANNERS OFFERED BY KEY MARKET PLAYERS
  • TABLE 36 OTHER SCANNERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 DIGITAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS
  • TABLE 38 DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 39 DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 INTEGRATED SOFTWARE OFFERED BY KEY MARKET PLAYERS
  • TABLE 41 INTEGRATED SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 43 STANDALONE SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 INFORMATION MANAGEMENT SOFTWARE OFFERED BY KEY MARKET PLAYERS
  • TABLE 45 INFORMATION MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 IMAGE ANALYSIS SOFTWARE OFFERED BY KEY MARKET PLAYERS
  • TABLE 47 IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION)
  • TABLE 49 CLOUD-BASED SOFTWARE OFFERED BY KEY MARKET PLAYERS
  • TABLE 50 CLOUD-BASED MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 ON-PREMISE SOFTWARE OFFERED BY KEY MARKET PLAYERS
  • TABLE 52 ON-PREMISE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 HYBRID SOFTWARE OFFERED BY KEY MARKET PLAYERS
  • TABLE 54 HYBRID MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 STORAGE SYSTEMS OFFERED BY KEY MARKET PLAYERS
  • TABLE 56 DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 58 HUMAN DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 VETERINARY DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 61 SOFTWARE IMPACT ANALYSIS, BY APPLICATION
  • TABLE 62 DIGITAL PATHOLOGY APPLICATIONS IN DRUG DISCOVERY
  • TABLE 63 DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 67 SOFTWARE IMPACT ANALYSIS, BY END USER
  • TABLE 68 DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS IN HOSPITALS
  • TABLE 70 DIGITAL PATHOLOGY MARKET FOR HOSPITALS AND REFERENCE LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 72 DIGITAL PATHOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 73 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 75 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 77 NORTH AMERICA: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 78 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION)
  • TABLE 79 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 80 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 81 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 82 US: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
  • TABLE 83 US: KEY MACROINDICATORS
  • TABLE 84 US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 85 US: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 86 US: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 87 US: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 88 US: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION)
  • TABLE 89 US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 90 US: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 91 US: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 92 CANADA: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
  • TABLE 93 CANADA: FUNDING INITIATIVES FOR DIGITAL PATHOLOGY
  • TABLE 94 CANADA: KEY MACROINDICATORS
  • TABLE 95 CANADA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 96 CANADA: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 97 CANADA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 98 CANADA: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 99 CANADA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODE, 2022–2029 (USD MILLION)
  • TABLE 100 CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 101 CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 102 CANADA: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 103 EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 105 EUROPE: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 EUROPE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 107 EUROPE: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 108 EUROPE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION)
  • TABLE 109 EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 111 EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 112 GERMANY: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
  • TABLE 113 GERMANY: KEY MACROINDICATORS
  • TABLE 114 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 115 GERMANY: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 116 GERMANY: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 GERMANY: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 118 GERMANY: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODE, 2022–2029 (USD MILLION)
  • TABLE 119 GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 120 GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 121 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 122 UK: CANCER INCIDENCE, BY TYPE, 2020 VS. 2040
  • TABLE 123 UK: KEY MACROINDICATORS
  • TABLE 124 UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 125 UK: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 UK: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 127 UK: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 128 UK: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODE, 2022–2029 (USD MILLION)
  • TABLE 129 UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 130 UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 131 UK: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 132 SWEDEN: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
  • TABLE 133 SWEDEN: KEY MACROINDICATORS
  • TABLE 134 SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 135 SWEDEN: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 136 SWEDEN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 137 SWEDEN: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 138 SWEDEN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODE, 2022–2029 (USD MILLION)
  • TABLE 139 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 140 SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 141 SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 142 DENMARK: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
  • TABLE 143 DENMARK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 144 DENMARK: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 145 DENMARK: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 146 DENMARK: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 147 DENMARK: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODE, 2022–2029 (USD MILLION)
  • TABLE 148 DENMARK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 149 DENMARK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 150 DENMARK: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 151 FRANCE: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
  • TABLE 152 FRANCE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 153 FRANCE: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 FRANCE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 155 FRANCE: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 156 FRANCE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODE, 2022–2029 (USD MILLION)
  • TABLE 157 FRANCE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 158 FRANCE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 159 FRANCE: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 160 SPAIN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 161 SPAIN: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 162 SPAIN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 163 SPAIN: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 SPAIN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION)
  • TABLE 165 SPAIN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 166 SPAIN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 167 SPAIN: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 168 ITALY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 169 ITALY: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 170 ITALY: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 171 ITALY: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 172 ITALY: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODE, 2022–2029 (USD MILLION)
  • TABLE 173 ITALY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 ITALY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 175 ITALY: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 176 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 177 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 178 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 179 REST OF EUROPE: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 180 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION)
  • TABLE 181 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 182 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 183 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 184 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 185 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 186 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 187 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 189 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION)
  • TABLE 190 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 191 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 192 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 193 CHINA: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
  • TABLE 194 CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 195 CHINA: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 196 CHINA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 197 CHINA: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 198 CHINA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODE, 2022–2029 (USD MILLION)
  • TABLE 199 CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 200 CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 201 CHINA: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 202 JAPAN: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
  • TABLE 203 JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 204 JAPAN: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 205 JAPAN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 206 JAPAN: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 207 JAPAN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION)
  • TABLE 208 JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 209 JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 210 JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 211 INDIA: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
  • TABLE 212 INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 213 INDIA: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 214 INDIA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 215 INDIA: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 216 INDIA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODE, 2022–2029 (USD MILLION)
  • TABLE 217 INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 218 INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 219 INDIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 220 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 221 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 222 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 223 REST OF ASIA PACIFIC: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 224 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODE, 2022–2029 (USD MILLION)
  • TABLE 225 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 226 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 227 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 228 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 229 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 230 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 231 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 LATIN AMERICA: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 233 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION)
  • TABLE 234 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 235 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 236 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 237 BRAZIL: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
  • TABLE 238 BRAZIL: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 239 BRAZIL: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 240 BRAZIL: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 241 BRAZIL: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 242 BRAZIL: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODE, 2022–2029 (USD MILLION)
  • TABLE 243 BRAZIL: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 244 BRAZIL: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 245 BRAZIL: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 246 MEXICO: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
  • TABLE 247 MEXICO: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 248 MEXICO: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 249 MEXICO: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 250 MEXICO: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 251 MEXICO: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION)
  • TABLE 252 MEXICO: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 253 MEXICO: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 254 MEXICO: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 255 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 256 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 257 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 258 REST OF LATIN AMERICA: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 259 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION)
  • TABLE 260 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 261 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 262 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 263 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 264 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 265 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 266 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 267 MIDDLE EAST & AFRICA: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 268 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION)
  • TABLE 269 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 270 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 271 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 272 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 273 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 274 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 275 GCC COUNTRIES: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 276 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODE, 2022–2029 (USD MILLION)
  • TABLE 277 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 278 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 279 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 280 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 281 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 282 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 283 REST OF MIDDLE EAST & AFRICA: STANDALONE SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 284 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2029 (USD MILLION)
  • TABLE 285 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 286 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 287 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 288 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • TABLE 289 DIGITAL PATHOLOGY MARKET: DEGREE OF COMPETITION
  • TABLE 290 DIGITAL PATHOLOGY MARKET: PRODUCT FOOTPRINT
  • TABLE 291 DIGITAL PATHOLOGY MARKET: APPLICATION FOOTPRINT
  • TABLE 292 DIGITAL PATHOLOGY MARKET: END-USER FOOTPRINT
  • TABLE 293 DIGITAL PATHOLOGY MARKET: REGION FOOTPRINT
  • TABLE 294 DIGITAL PATHOLOGY MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 295 DIGITAL PATHOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 296 DIGITAL PATHOLOGY MARKET: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2021–MARCH 2024
  • TABLE 297 DIGITAL PATHOLOGY MARKET: DIGITAL PATHOLOGY MARKET: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 298 DIGITAL PATHOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024
  • TABLE 299 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 300 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 301 DANAHER CORPORATION: PRODUCT ENHANCEMENTS, JANUARY 2021−JUNE 2024
  • TABLE 302 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 303 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 304 KONINKLIJKE PHILIPS N.V: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 305 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021−JUNE 2024
  • TABLE 306 HAMAMATSU PHOTONICS K.K.: COMPANY OVERVIEW
  • TABLE 307 HAMAMATSU PHOTONICS K.K.: PRODUCTS OFFERED
  • TABLE 308 HAMAMATSU PHOTONICS K.K.: PRODUCT APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 309 HAMAMATSU PHOTONICS K.K.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 310 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 311 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
  • TABLE 312 HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 313 HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 314 SECTRA AB: COMPANY OVERVIEW
  • TABLE 315 SECTRA AB: PRODUCTS OFFERED
  • TABLE 316 SECTRA AB: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 317 SECTRA AB: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
  • TABLE 318 AKOYA BIOSCIENCES, INC.: COMPANY OVERVIEW
  • TABLE 319 AKOYA BIOSCIENCES, INC.: PRODUCTS OFFERED
  • TABLE 320 AKOYA BIOSCIENCES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 321 AKOYA BIOSCIENCES, INC.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 322 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 323 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
  • TABLE 324 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 325 HOLOGIC, INC: COMPANY OVERVIEW
  • TABLE 326 HOLOGIC, INC: PRODUCTS OFFERED
  • TABLE 327 HOLOGIC, INC: PRODUCT APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 328 3DHISTECH LTD.: COMPANY OVERVIEW
  • TABLE 329 3DHISTECH LTD.: PRODUCTS OFFERED
  • TABLE 330 3DHISTECH LTD.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–JUNE 2024
  • TABLE 331 3DHISTECH LTD.: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
  • TABLE 332 APOLLO ENTERPRISE IMAGING CORP.: COMPANY OVERVIEW
  • TABLE 333 APOLLO ENTERPRISE IMAGING CORP.: PRODUCTS OFFERED
  • TABLE 334 APOLLO ENTERPRISE IMAGING CORP.: PRODUCT ENHANCEMENTS, JANUARY 2021–JUNE 2024
  • TABLE 335 APOLLO ENTERPRISE IMAGING CORP.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 336 XIFIN, INC.: COMPANY OVERVIEW
  • TABLE 337 XIFIN, INC.: PRODUCTS OFFERED
  • TABLE 338 XIFIN, INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 339 XIFIN, INC.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 340 HURON DIGITAL PATHOLOGY: COMPANY OVERVIEW
  • TABLE 341 HURON DIGITAL PATHOLOGY: PRODUCTS OFFERED
  • TABLE 342 HURON DIGITAL PATHOLOGY: PRODUCT APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 343 HURON DIGITAL PATHOLOGY: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 344 HURON DIGITAL PATHOLOGY: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
  • TABLE 345 CORISTA: COMPANY OVERVIEW
  • TABLE 346 CORISTA: PRODUCTS OFFERED
  • TABLE 347 CORISTA: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 348 CORISTA: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
  • TABLE 349 INDICA LABS: COMPANY OVERVIEW
  • TABLE 350 INDICA LABS: PRODUCTS OFFERED
  • TABLE 351 INDICA LABS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 352 INDICA LABS: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 353 OBJECTIVE PATHOLOGY SERVICES: COMPANY OVERVIEW
  • TABLE 354 OBJECTIVE PATHOLOGY SERVICES: PRODUCTS OFFERED
  • TABLE 355 OPTRASCAN, INC.: COMPANY OVERVIEW
  • TABLE 356 OPTRASCAN, INC.: PRODUCTS OFFERED
  • TABLE 357 OPTRASCAN, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 358 OPTRASCAN, INC.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 359 GLENCOE SOFTWARE, INC.: COMPANY OVERVIEW
  • TABLE 360 GLENCOE SOFTWARE, INC.: PRODUCTS OFFERED
  • TABLE 361 GLENCOE SOFTWARE, INC.: PRODUCT ENHANCEMENTS, JANUARY 2021–JUNE 2024
  • TABLE 362 AIFORIA TECHNOLOGIES OY: COMPANY OVERVIEW
  • TABLE 363 AIFORIA TECHNOLOGIES OY: PRODUCTS OFFERED
  • TABLE 364 AIFORIA TECHNOLOGIES OY: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 365 PAIGE AI, INC.: COMPANY OVERVIEW
  • TABLE 366 PAIGE AI, INC.: PRODUCTS OFFERED
  • TABLE 367 PAIGE AI, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–JUNE 2024
  • TABLE 368 PAIGE AI, INC.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 369 PROSCIA, INC.: COMPANY OVERVIEW
  • TABLE 370 PROSCIA, INC.: PRODUCTS OFFERED
  • TABLE 371 PROSCIA, INC.: PRODUCT ENHANCEMENTS & APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 372 PROSCIA, INC.: DEALS, JANUARY 2021–JUNE 2024
LIST OF FIGURES
 
  • FIGURE 1 DIGITAL PATHOLOGY MARKET
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY DEMAND SIDE, SUPPLY SIDE, DESIGNATION, AND REGION
  • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 7 DIGITAL PATHOLOGY MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION OF DANAHER CORPORATION
  • FIGURE 8 BOTTOM-UP APPROACH
  • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN DIGITAL PATHOLOGY MARKET (2024–2029)
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • FIGURE 12 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 DIGITAL PATHOLOGY MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 DIGITAL PATHOLOGY MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 GEOGRAPHIC SNAPSHOT OF DIGITAL PATHOLOGY MARKET
  • FIGURE 17 RISING INCIDENCE OF CANCER AND GROWING ADOPTION OF PATHOLOGY SOLUTIONS FOR ENHANCED LAB EFFICIENCY TO DRIVE MARKET
  • FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 19 UK TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 20 ASIA PACIFIC SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 21 DIGITAL PATHOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 GLOBAL CANCER INCIDENCE, 2008−2030
  • FIGURE 23 FDA-APPROVED PERSONALIZED MEDICINES, 2015−2021
  • FIGURE 24 DIGITAL PATHOLOGY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 DIGITAL PATHOLOGY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 26 DIGITAL PATHOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 27 EUROPE: IVDR TIMELINE
  • FIGURE 28 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIGITAL PATHOLOGY PATENTS, 2013–2023
  • FIGURE 29 MAJOR PATENTS FOR DIGITAL PATHOLOGY (2013–2023)
  • FIGURE 30 KEY BUYING CRITERIA FOR DIGITAL PATHOLOGY PRODUCTS
  • FIGURE 32 MARKET POTENTIAL OF GENERATIVE AI IN ENHANCING DIGITAL PATHOLOGY ACROSS INDUSTRIES
  • FIGURE 33 IMPACT OF GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
  • FIGURE 34 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 35 EUROPE: DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN DIGITAL PATHOLOGY MARKET
  • FIGURE 37 DIGITAL PATHOLOGY MARKET: MARKET SHARE ANALYSIS (2023)
  • FIGURE 38 DIGITAL PATHOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 39 DIGITAL PATHOLOGY MARKET: COMPANY FOOTPRINT
  • FIGURE 40 DIGITAL PATHOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF DIGITAL PATHOLOGY VENDORS
  • FIGURE 43 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 44 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
  • FIGURE 45 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2023)
  • FIGURE 46 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 47 SECTRA AB.: COMPANY SNAPSHOT (2023)
  • FIGURE 48 AKOYA BIOSCIENCES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 49 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 50 HOLOGIC, INC: COMPANY SNAPSHOT (2023)

The study involved five major activities to estimate the current size of the Digital Pathology market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of Digital Pathology Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global Digital Pathology market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews

The following is a breakdown of the primary respondents:

Breakdown of Primary Participants:

Digital Pathology Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Tiers of companies are defined on the basis of their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the Digital Pathology market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Global Digital Pathology Market Size: Bottom-Up Approach

Digital Pathology Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Digital Pathology Market Size: Top-Down Approach

Digital Pathology Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Digital Pathology Market.

Market Definition:

Digital pathology refers to the use of digital technology to capture, manage, share, and analyze pathology information, typically in the form of high-resolution digital images derived from glass slides. This technology allows pathologists to view, interpret, and manage pathology data more efficiently and accurately.

Key Stakeholders:

  • Healthcare institutions/providers (hospitals, medical groups, physician practices, diagnostic centers, pharmacies, ambulatory centers, and outpatient clinics)
  • Digital Pathology organizations
  • Senior Management
  • Finance/Procurement Department
  • R&D Department
  • Healthcare data aggregators
  • Venture capitalists
  • Government agencies
  • Healthcare startups, consultants, and regulators
  • Academic medical institutes

Report Objectives

  • To define, describe, and forecast the global Digital Pathology market based on product, type, application, end user, and region.
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall Digital Pathology market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To strategically analyze the market structure profile the key players of the Digital Pathology market and comprehensively analyze their core competencies.
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To track and analyze competitive developments such as product launches and enhancements and investments, partnerships, collaborations, acquisitions, expansions, agreements, sales contracts, and alliances in the Digital Pathology market during the forecast period.

Available Customizations:

MarketsandMarkets offers the following customizations for this market report:

  • Product matrix, which gives a detailed comparison of the product portfolios of the top companies
  • Further breakdown of the Rest of the Asia Pacific digital pathology market into South Korea, Australia, New Zealand, and other countries
  • Further breakdown of the Rest of Europe digital pathology market into Italy, Spain, Belgium, Russia, the Netherlands, Switzerland, and other countries
  • Detailed analysis and profiling of additional market players (up to 5)

Previous Versions of this Report

Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals) & Region - Global Forecast to 2026

Report Code HIT 2608
Published in Jun, 2023, By MarketsandMarkets™

Digital Pathology Market by Product( ArtificiaI Intelligence, Scanner, Software, Storage), Type(Human, Veterinary), Application( Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User( Pharma, Academia, Hospitals ) - Global Forecast to 2026

Report Code HIT 2608
Published in Mar, 2022, By MarketsandMarkets™

Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End-User (Pharmaceutical Companies, Hospitals) - Global Forecast to 2025

Report Code HIT 2608
Published in Oct, 2020, By MarketsandMarkets™

Digital Pathology Market by Application (Disease Diagnosis, Drug Discovery, Teleconsultation), Product (Scanner, Software, Communication System), Type (Human, Veterinary), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2022

Report Code HIT 2608
Published in Mar, 2020, By MarketsandMarkets™

Digital Pathology Market by Product (Scanner, Software, Communication System), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2022

Report Code HIT 2608
Published in Oct, 2017, By MarketsandMarkets™

Digital Pathology Market by Product (Scanners, Software), by Type (Human, Animal Pathology), by End User (Pharmaceutical Company, Hospital, Academic Institutions), by Application (Teleconsultation, Drug Discovery) - Global Forecasts to 2021

Report Code HIT 2608
Published in May, 2016, By MarketsandMarkets™

Digital Pathology Market by Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & by Whole Slide Image Storage - Global Forecasts & Trends to 2018

Report Code HIT 2608
Published in Aug, 2014, By MarketsandMarkets™

Digital Pathology Market by Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & by Whole Slide Image Storage - Global Forecasts & Trends to 2018

Report Code HIT 2608
Published in Jan, 2011, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Digital Pathology Market

Jamie

Jul, 2022

Keen to Know about Digital Pathology Market Size, Share and Trend Analysis Report by Product (ArtificiaI Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), and Pharma, Diagnostic Labs, Hospitals as well as Academia, Hospitals - Global Forecast to 2031.

Jason

Mar, 2022

Looking to gain more insights on the global Industrial Digital Pathology Market.

Jeffrey

Mar, 2022

What are the growth opportunities in Digital Pathology Market?.

Jeffrey

Mar, 2022

What are the growth opportunities in Digital Pathology Market?.

Ryan

Mar, 2022

Can you enlighten us on geographical growth analysis in Digital Pathology Market?.

DMCA.com Protection Status